Monday, October 14

Healthcare

Lisata jumps on FDA orphan drug status for bile duct cancer drug

09/08/20241 Min Read

bile cancer drug duct FDA jumps Lisata orphan status

Previous ArticleAscendis raised to outperform by Oppenheimer ahead of drug launch

Next Article Eli Lilly bets $409M for AI-focused drug discovery